id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2000-N-0139-0003,FDA,FDA-2000-N-0139,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Changes to an Approved New Drug Application or Abbreviated New Drug Application,Notice,General Notice,2004-03-24T05:00:00Z,2004,3,2004-03-16T05:00:00Z,2004-04-17T03:59:59Z,2025-06-12T20:09:29Z,04-5832,0,0,09000064804d0bc2
FDA-2000-N-0139-0002,FDA,FDA-2000-N-0139,Agency Information Collection Activities; Comment Request; Guidance for Industry-Changes to an Approved New Drug Application or Abbreviated New Drug Application,Notice,General Notice,2003-12-30T05:00:00Z,2003,12,2003-12-19T05:00:00Z,2004-02-18T04:59:59Z,2025-06-12T20:08:33Z,03-31412,0,0,09000064804d0bb0
FDA-2000-N-0139-0001,FDA,FDA-2000-N-0139,Agency Information Collection Activities; Proposed Collection; Comment Request; Guidance for Industry: Changes to an Approved NDA or ANDA,Notice,General Notice,2000-09-12T04:00:00Z,2000,9,2000-09-07T04:00:00Z,2000-11-07T04:59:59Z,2025-06-12T20:06:56Z,00-22948,0,0,09000064804d0b88